



Investigating Molecular Mechanisms of Calcium Signaling in 
Bacterial Pathogen Pseudomonas aeruginosa 
 





Advisor: Dr. M.A. Patrauchan 


















Pseudomonas aeruginosa is a human pathogen that causes acute and chronic infections 
[1] [2]. P. aeruginosa infections cause cellular damage and airway blockage by forming biofilms 
in the respiratory systems of cystic fibrosis (CF) patients. These biofilm infections are often not 
treatable using antibiotics [3] [4] [5]. For these reasons, P. aeruginosa infections are a leading 
cause of death in patients with CF [6] [7].  
Calcium (Ca2+) is a signaling ion whose regulatory role has been extensively studied in 
eukaryotes and shown to be essential in orchestrating many essential biological processes [8]. 
Abnormal cellular Ca2+ homeostasis is associated with multiple diseases, including pulmonary 
infections in CF patients, and the dysregulation of Ca2+ metabolism has been shown to contribute 
to CF pathology [9]. It has been shown to accumulate in the respiratory systems of CF patients 
[10]. Furthermore, Ca2+ plays a role in host response to bacterial infection [11].  
Ca2+ has also been shown to influence bacterial physiology [12]-[16]. P. aeruginosa, 
among other bacteria, is able to maintain intracellular Ca2+ homeostasis as well as respond to 
Ca2+ in the environment [17] [18] [19]. Currently, however, the molecular mechanisms of Ca2+-
signaling have not been adequately studied in prokaryotes. Research in Patrauchan’s lab has 
shown that increased levels of Ca2+ induce the production of several virulence factors in P. 
aeruginosa, including extracellular proteases, alginate, pyocyanin, formation of biofilm, and 
antibiotic resistance [20].  
In order to study the molecular mechanisms regulating Ca2+-induced virulence in P. 
aeruginosa, the Patrauchan lab had predicted several putative Ca2+-binding proteins. The group 
identified the only calmodulin-like protein encoded in the P. aeruginosa genome, EfhP. This 
protein contains two canonical Ca2+-binding EF-hand domains [20]. EfhP was also shown to be 
involved in mediating Ca2+-regulated virulence and resistance in the pathogen [20]. EfhP is 
predicted to be one component of a Ca2+-signaling network. However, its specific role in this 




The principal goal of my research has been to elucidate the role that EfhP plays in 
regulating Ca2+-induced virulence of P. aeruginosa. To achieve this goal, I aimed to: (1) purify 
EfhP and measure its Ca2+-binding properties, (2) identify specific amino acids binding Ca2+ in 
EfhP, and (3) study the environmental factors affecting transcriptional regulation of the encoding 
gene, efhP. This knowledge is imperative for characterizing the functional role of EfhP. 
Considering the importance of Ca2+ signaling in a host, its understanding would provide an 
insight into the regulatory networks orchestrating virulence and interactions with a host in P. 
aeruginosa. The latter is essential for future development of novel therapeutic approaches for 
preventing or controlling Pseudomonas infections. 
 
METHODS AND MATERIALS 
Heterologous expression and purification of EfhP 
The wild-type strain of P. aeruginosa, PAO1, was used for this study. The predicted 
cytoplasmic portion of efhP, represented in Figure 1, was cloned into the vector pET-15b, shown 
in Figure 2, which has ampicillin resistance for antibiotic selection as well as a TEV protease 
cleavage site for removal of His-tag in the purified protein.  
 
Figure 1. EfhP is a transmembrane protein with two 
EF-Hand domains. These domains have a helix-turn-
helix structure and are known to bind Ca2+. 
Figure 2. efhP was cloned into the vector pET-15b 




The soluble portion of efhP was amplified by PCR from the PAO1 genome using gene 
specific primers efhP_OM forward and efhP reverse, shown in Table 1. The amplicon was 
digested for 3 hours at 37°C along with the cloning vector pET15b using restriction enzymes 
BamHI and NdeI. efhP was then cloned into pSKB3 using a Quick Ligation kit (NEB). The 
ligation mixture was incubated at room temperature for 15 minutes. The resulting construct, 
named pDAV, contained efhP between the BamHI and NdeI restriction sites under the IPTG-
inducible promoter. It was transformed by using heat-shock transformation protocol [21]. For 
this, the ligated vector was added to heat shock competent DH5α E. coli cells, kept on ice for 30 
minutes, incubated at 42°C for 45 seconds, then kept on ice for an additional 10 minutes. The 
cells were then transferred to 1mL LB broth in a glass tube and incubated for 2 hours at 37°C. 
150 µL of the cells were spread on LB agar plate with the selective antibiotic ampicillin 
(100µg/ml). Successful transformants were confirmed by PCR amplification followed by DNA 
sequencing. 
For protein purification, pDAV was transformed into the expression strain DE3 E. coli 
using the heat shock protocol described above. The expression cells were grown in 50mL LB 
broth with 100mg/mL ampicillin at 37°C shaking overnight. 10mL of this culture was used to 
inoculate 1L LB broth + 100mg/mL ampicillin and incubated at 37°C shaking for approximately 
3 hours. When the OD of this culture reached 0.6, 2mL of 0.5M IPTG was added to induce 
expression of EfhP, and the culture was grown in the same conditions for 3 additional hours. The 
culture was divided into four 250mL centrifuge bottles and pelleted by centrifuging at 12,000 
rpm for 30 minutes. The supernatant was discarded and the cells were stored at -20°C. 
For cell lysis, the frozen pellets were thawed on ice. The cells were resuspended in 50mL 
buffer A: 20 mM Tris, 500 mM NaCl, 10% glycerol, 20 mM Imidazole, pH 7.8. Lysozyme was 
added to final concentration of 0.5mg/mL. The cells were incubated on ice for 40 minutes. The 
lysate was sonicated 8 seconds on, 8 seconds off for 1 minute 30 seconds. The cells were 
centrifuged at 12,000rpm for 30 minutes at 4°C. The supernatant was collected and incubated 




rocker in cold room, rocking for 1 hour. Thus charged Ni-NTA resin was transferred into a 25 ml 
gravity flow column and washed with 100mL of pre-chilled buffer A. The protein was eluted by 
using 20ml buffer B (20mM Tris, 500mM NaCl, 10% glycerol, 250mM Imidazole, pH 7.8) . The 
eluates were collected in fractions of 1.5ml in microcentrifuge tubes. The eluates were analyzed 
by SDS-PAGE to confirm the presence of the purified protein with correct molecular weight.  
In order to cleave off the N-terminal 6X His-tag, the eluates containing the protein were 
pooled together and treated with recombinant Tobacco Etch Virus (rTEV) protease in 1:40 molar 
ratio (TEV: protein sample). The mixture was transferred into a dialysis membrane of molecular 
weight cutoff value 12-14KDa and subjected to dialysis against 1L buffer: 20 mM Tris, 500 mM 
NaCl, 10% glycerol, pH 8.0 in the 4°C cold room overnight. To prepare for removing the 
cleaved His-tag fragment and His-tag rTEV, the Ni-NTA resin was washed with 50 ml buffer B 
and then 100 ml pure water, then 30 ml buffer A. The column was equilibrated with 30mL 
dialysis buffer. The dialyzed protein sample was transferred into the column and let flow through 
the column 3 times by gravity flow. Buffer A was used to wash out any residual His-tag cleaved 
protein attached to the column. Finally buffer B was used to elute all the uncleaved His-tagged 
protein from the column. These fractions along with the flow through were analyzed by running 
on a SDS-PAGE to verify the efficiency of digestion.  
 The digested protein was concentrated by using a spin-column with 10K MW cut-off 
(Millipore) to achieve 5-10 mg/ml final protein concentration. The concentrated protein was 
aliquoted into 50 ul in thin-wall PCR tubes and frozen by immersing the tubes into the liquid 
nitrogen by using a pair of forceps. All tubes were then placed into a 50 ml falcon tube with 
proper labels and stored at -80°C for further analyses. 
 
Measuring EfhP Ca2+-binding capabilities 
ITC measurements were performed with a Nano-Isothermal Titration Calorimeter III 
(Calorimetry Sciences Corporation, Utah, USA). Frozen EfhP_NO_TM was thawed and 




diluted 5 times with nanopure water. Absorbance was read at 595nm by using a 
spectrophotometer (Thermo Scientific). HEPES buffer (20mM HEPES, 100mM NaCl, pH 7) 
was used to dilute the protein sample to make the concentration 100µM. A 1mM solution of 
Calcium chloride (CaCl2) was prepared in HEPES buffer. Prior to titration, both the protien and 
CaCl2 were centrifuged for 1 minute at 4C, 14000 rpm in a spin filter (VWR) with nylon 
membrane of pore size 0.2µM. A total of 1ml of this filtered protein was titrated with a total of 
250µl CaCl2. The titration consisted of injecting 10µl aliquots of 1mM CaCl2 solution into the 
protein every 300 seconds. A total of 20 injections were carried out. The ITC data was analyzed 
using the software Bindworks (supplied with Nano-Isothermal Titration Calorimeter III). The 
amount of heat released per addition of the titrant was fitted to the ‘independent set of multiple 
binding sites’ model.   
To characterize changes in protein surface hydrophobicity, 8-anilino-1-
naphthalenesulfonic acid (ANS) from Molecular Probes was used. In a 1ml quartz cuvette of 
cross section 5mm X 5mm, 10µM protein was mixed with 50µM ANS. Fluorescence 
measurements were conducted on a Horiba Jobin Yvon (HJY) Fluoromax 3 spectrofluorimeter 
(JOBIN YVON-SPEX). The excitation wavelength for ANS was 350 nm. The excitation and 
emission bandwidths were set at 5 nm. Spectral scan was carried out from 400 to 600 nm.  The 
effect of Ca2+ or Mg2+ on the EfhP-ANS fluorescence was determined by adding CaCl2 or MgCl2 
prepared in HEPES buffer to the cuvette. Spectra were collected for each Ca2+ or Mg2+ 
concentration from 10 to 100µM. As controls, spectra HEPES buffer alone and for 50µM ANS 
in HEPES were collected. Maximum fluorescence Intensity of the EfhP + ANS mixture was 
subtracted from maximum fluorescence intensities measured at different Ca2+ or Mg2+ 
concentrations.  These differences were plotted against the Ca2+ concentration. Similar 
experiment was carried out with the mutant protein EFhPD88N. All the measurements were done 






Replacing amino acids by site directed mutagenesis 


















   
 
Figure 3. This BLAST of the translation of the retrieved DNA with PA4107_NO_TM 
shows the mutation D88N in EfhP is made by the point mutation G305A. 
Figure 4. EfhP is shown with amino acid sequences of both EF-hands. The 





Primers PA4017_D1N forward and reverse, shown in Table 1, containing the desired 
mutation were designed, and the vector containing the mutated gene was generated by using 
inverse PCR with the expression vector containing the wild-type No-TM-EfhP as the template. 
The PCR mixture contained 10µL DreamTaq Green PCR Master Mix, 1.5µL 2.5mM dNTPs 
(extra), 1µL forward primer, 1µL reverse primer, 1µL DNA template, and 5.5µL dH2O for a total 
20µL of reaction mixture. The denaturation step was programed to run at 95°C for 30 seconds, 
and the annealing step was programed to run at 56°C for 30 seconds. To enable amplification of 
the entire vector, the elongation phase of the reaction was programed to run for 2 minutes, (1 
minute longer than usual), at 72°C . The reaction was only run for 19 cycles. To eliminate the 
original template, the PCR product received 1µL of the restriction enzyme DpnI and incubated in 
a 37°C water bath for 6 hours. Sufficient incubation time and amount of enzyme was established 
by observing no transformants after digesting template pDAV under the conditions mentioned 
above then heat shocking the digested plasmid into E. coli. The digested product was then 
transformed into heat shock competent DH5α E. coli cells using the protocol described above. 
Successful transformants were selected on agar plates with 50ng/µL kanamycin and confirmed 
by DNA sequencing. Once confirmed, the mutated soluble EfhP, EfhP_D88N was purified using 












Primer Name Primer Sequences Primer Function 
efhP_OM/efhP F: AGA GAG CAT ATG GAG 
CCG CTG GGC CAG 
R: AGA GAG GGA TCC TCA 
GTG CTG GCC TTG 
Used to amplify the predicted 
cytoplasmic portion of efhP 
for heterologous expression 
and purification of EfhP 
PA4107_D1N F: GAC GCC TCC TTT GCC CGA 
ACC AAC ACC GAT CAC CAT 
GGC 
R: GCC ATC GTG ATC GGT GTT 
GGT TCG GGC AAA GGA GGC 
GTC 
Used to make point mutation 
to generate mutant 
EfhP_D88N 
PA4107_UP F: TAA GCA CTC GAG GCC 
AGG TGG CTG TC 
R: TAA GCA GGA TCC GCT TCT 
TCT CCA CAG 
Used to amplify the intergenic 
region upstream of efhP in 
order to generate promoter 
construct 
 
Promoter activity construct and assays 
 To study the transcriptional regulation of efhP, a promoter construct pREN was generated 
by cloning the intergenic region upstream of efhP into the vector pCTX-1-lux between restriction 










Figure 5. pCTX-1-lux is an integrase 
plasmid featuring the lux operon that will 




First, the intergenic region containing predicted promoter sequence upstream of the gene was 
amplified by PCR using the primers PA4107_UP forward and reverse, shown in Table 1. The 
amplified intergenic region and the vector pCTX-1-lux were digested using restriction enzymes 
BamHI and XhoI for 3 hours at 37°C. The promoter sequence was then cloned into pCTX-1-lux 
using a Quick Ligation kit (NEB). The ligation mixture containing 5µL vector and 4µL insert 
was incubated at room temperature for 15 minutes. For transformation, the ligation mixture was 
added to heat shock competent DH5α E. coli cells and transformed using the protocol described 
above. The successful transformants were selected on LB agar plates containing 20ng/µL 
tetracycline.  
Once the promoter construct pREN was confirmed by DNA sequencing, it was 
transformed into PAO1 by electroporation [21]. For this, PAO1 was grown in LB broth at 37°C 
shaking overnight. The cells from 1.5mL culture were pelleted in microcentrifuge tubes and 
washed 3 times with 300mM sucrose, starting with 1mL and decreasing the volume by half with 
each wash. pREN was then added to the competent cells, mixed, and exposed to 1 pulse of 
electric shock (setting #2) of a BioRad electroporator. The cells were then transferred to glass 
tubes containing 1mL SOC and incubated for 2 hours shaking at 37°C. 150µL of the culture was 
then plated onto LB agar + 60mg/mL tetracycline. Successful transformants were screened by 
measuring increased luminescence.  
Empty pCTX-1-lux was transformed into PAO1 to be used as a control using di-parental 
mating [22]. For this, donor SM10 E. coli cells containing the empty vector as well as the 
recipient PAO1 cells were grown in LB broth overnight at 37°C shaking. 1mL of the PAO1 
culture was incubated at 42°C for 2 hours while 50µL of the SM10 cells were spot dried onto LB 
agar. 100µL of the PAO1 cells were spot dried directly on top of the E. coli. The mating mixture 
was then incubated at 37°C overnight. The following day, the mixed cells were resuspended in 
PBS and 50µL was spread onto PIA agar + 60mg/mL tetracycline.  
To study the role of two component transcriptional regulators in regulating transcription 




mating protocol described above. Promoter activity assays were conducted using a Biotek 96-
well plate reader. To prepare inoculum, 3mL cultures of the desired strains were grown in BMM 
for 12 hours. The ODs were normalized to 0.3 by diluting cultures in BMM. 10µL of the 
normalized culture was mixed with 990µL of BMM containing 0, 1, 3, 5, and 10mM Ca2+. A 
white, flat-bottomed 96-well plate was inoculated with 100µL of each culture in 5 replicates. The 
plate was then incubated in the Biotek 96-well plate reader at 37°C shaking on the fast setting. 
Luminescence and absorbance at 600nm were measured every 30 minutes for 24 hours. 
Luminescence measurements were normalized by Ab600 of the corresponding cultures, followed 
by subtraction of the empty vector normalized luminescence. Finally, ratios between promoter 
activities determined with and without Ca2+ were calculated and averaged over at least three 
biological replicates. Every experiment was repeated at least twice.   
 
RESULTS AND DISCUSSION 
Heterologous expression and purification of EfhP 
In order to avoid protein aggregation, to purify EfhP, only the portion of the gene 
encoding the predicted cytoplasmic part of the protein was cloned into the vector pET15b. The 
latter features ampicillin resistance marker for antibiotic selection as well as a TEV protease 
cleavage site used for cleaving the His-tag. The resulting construct pDAV is shown in Figure 6. 
Figure 6. The construct pDAV was generated 




Following purification, the purified protein was confirmed as EfhP by SDS-PAGE and 
MALDI-TOF mass spectrometry. The image of the SDS-PAGE gel with estimated sizes of the 




A monomeric form of EfhP was needed to study Ca2+-binding and to characterize the 
kinetics of this binding. As shown in Figure 8, size exclusion chromatography was used to 













Figure 7. Molecular weight of the protein samples was estimated 
by SDS-PAGE. The undigested protein contained His-tags used 
for purification. The digested sample was treated with TEV to 
remove His-tags. 




Measuring EfhP Ca2+-Binding: 
The Ca2+-binding capabilities of EfhP were measured by ITC. A titration curve resulting 






 The curve was fit to the ‘independent set of multiple binding sites’ model using the 
Bindworks software, which revealed an exothermic nature of the binding reaction. The binding 
enthalpy (ΔH) was -43.7KJ/mol, while the dissociation constant (Kd) was 18.2µM. A titration 
curve resulting from addition of aliquots of Mg2+ to EfhP_NO_TM is shown in Figure 5. For 
Mg2+, the binding enthalpy (ΔH) of -0.24 KJ/mol. The heat generated by EfhP_NO_TM-Mg2+ is 
significantly lower than that generated by EfhP_NO_TM-Ca2+, which supports the hypothesis 
that EfhP_NO_TM specifically binds Ca2+ but not Mg2+. The high affinity and specificity of 
EfhP-Ca2+ binding support our hypothesis that EfhP functions as a Ca2+-binding sensor in a Ca2+-
signaling pathway.  
The EF-hand containing eukaryotic protein calmodulin (CaM) is known to bind to Ca2+ 
with Kd ranging from 10nM to 800µM [23] [24] [25]. Other eukaryotic EF hand proteins 
including secretagogin, a redox responsive Ca2+-sensor, and Ca2+-dependent protein kinases 
(CDPKs) were shown to have Kd values as low as 1µM and 5µM, respectively, indicating fairly 
high affinity Ca2+-binding [26][24]. It is noteworthy that CaM, secretagogin and CDPKs function 
as Ca2+-sensors. Cytosolic Ca2+ buffers like calbindin-D9k (CB-D9k), calbindin-D28k (CB-
D28k), parvalbumins and calretinin (CR) have Ca2+ dissociation constants that are in low 
Figure 9. Measurements of heat released by the 
binding of Ca2+ by Efhp over time were used to 
calculate a binding constant that shows EfhP’s 





micromolar ranges (0.2- 1.5µM) and unlike the sensors do not undergo conformational changes 
but help to spatiotemporally regulate cytosolic Ca2+ signals [28]. Considering the broad range of 
Ca2+ affinities among Ca2+-binding proteins with different function, it is difficult to predict what 
role EfhP plays in a cell based on its Kd.  However, taking into account that the intracellular 
level of Ca2+ in P. aeruginosa is about 0.1 µM, which increases to about 2-4 µM in response to 
elevated extracellular Ca2+ [19], and 1000 fold higher levels of Ca2+ in the periplasm as measured 
in E. coli [18]. Calmodulin has been shown to have Kd values as large as 104 µM indicating poor 
affinity [29]. In the present study we have observed very low heat generation from the binding of 
EfhP to Mg2+ that supports the expectation that EfhP selectively binds to Ca2+.   
 
Measuring Ca2+ induced changes in conformation of EfhP: 
Based on the homology of EfhP to eukaryotic calmodulin, we predicted that Ca2+-binding 
will lead to its conformational changes increasing hydrophobicity of the protein further enabling 
its Ca2+-dependent interactions with protein targets. Depending on the nature of the targets, this 
interaction is expected to activate their activity and thus transduce the Ca2+ signal. To 
characterize Ca2+-dependent hydrophobicity of EfhP, we measured the fluorescence of protein-
ANS complex in response to addition of either Ca2+ or Mg2+. The fluorescence of 
EfhP_NO_TM-ANS complex increased with increasing concentrations of Ca2+ up to 40µM Ca2+ 
(Fig.8).  However, such increase was not observed with increasing concentrations of Mg2+ (Fig. 
9). This supports the hypothesis that upon Ca2+-binding, EfhP undergoes conformational changes 
that lead to increase in hydrophobicity.  Further studies will aim to identify the targets of EfhP 
and their role in Ca2+ regulation. 
 
Replacing amino acids by site directed mutagenesis 
Based on the knowledge that the mutations of the first residue of the EF hand impairs 
Ca2+-affinity in calmodulin, cardiac and skeletal troponin C, and myosin regulatory light chain, 




[30]-[33]. Therefore we used site directed mutagenesis to obtain a mutant protein with impaired, 
if not abolished Ca2+-binding abilities. These experiments aim to not only identify the Ca2+-
binding amino acids in EfhP, but enable generating a mutated EfhP for further functional studies. 
Since earlier studies showed thay EfhP regulates Ca2+-dependent virulence in P. aeruginosa [20], 
we hypothesise this role of EfhP requires its ability to bind Ca2+. To prove this hypothesis, we 
plan to test Ca2+-dependent virulence factors in the efhP deletion mutant expressing the mutant 
EfhPD88N.  
The mutant protein EfhP_D88N was obtained by an inverse PCR of the gene carrying 
vector and making a point mutation changing one nucleotide from G to A, which replaced an 
aspartic acid with an asparagine in the first EF-Hand, as shown previously in Figure 3. The 






Measuring Ca2+-binding and Ca2+ induced changes in conformation of the mutated EfhP_D88N: 
To determine whether the mutation affected the ability of the mutated protein 
EfhP_D88N to bind Ca2+, the protein was purified and subjected to ITC measurements. Titrating 
with Ca2+ revealed that EfhP_D88N has a Kd value of 62.61µM for Ca2+, which is 3 folds higher 
than that for the wild-type protein (18.33µM). The titration curve for EfhP_D88N is shown in 
Figure 13. This higher Kd of the mutant protein implies a decrease in Ca2+ affinity. This shows 
that the first D of the first EF-hand loop has an important role in coordinating Ca2+ ion in the 
loop. 
Figure 10. The purification of mutant EfhP was visualized using SDS-
PAGE. The expected size of the mutant protein was 15.75kDA with 




In order to study whether the mutant protein EfhP_D88N undergoes conformational 
changes induced by Ca2+, we measured the fluorescence of protein-ANS complex in response to 
addition of either Ca2+ or Mg2+ and compared to the wild-type EfhP. The increase in fluorescence 
of the mutant protein EfhPD88N-ANS complex in response to adding Ca2+ was reduced in 
comparison to the wildtype protein. This proves that the first Aspartate (D) of the Ca2+-binding 













Figure 11. ANS analysis of EfhP and 
mutant EfhP_D88N in response to Ca2+ 
Figure 12. ANS analysis of EfhP and 
mutant EfhP_D88N in response to Mg2+ 














Figure 13. Titration curve for mutant protein 
EfhP_D88N shows a significant decrease in Ca2+-




Promoter activity construct and assays 
To identify the environmental factors controlling transcription of efhP, we generated 
promoter activity constructs. Promoter activity assays are being conducted to study the effects of 
extracellular Ca2+ levels on the transcription of efhP. The promoter construct pREN, an integrase 
plasmid, has been transformed into the wildtype P. aeruginosa strain PAO1, which will be 
grown in a variety of Ca2+ concentrations. The luminescence measured in these assays will show 
the transcriptional effects of environmental Ca2+. Similar assays will be conducted to investigate 
the effects of low iron, and elevated CO2. The results of these experiments will reveal what 
environmental factors play a role in regulating the transcription of efhP.  
Further studies are necessary to identify the partner proteins of EfhP cascading Ca2+-
signaling towards Ca2+-dependent processes. Obtaining the knowledge about this signaling 
pathway will generate an insight into Ca2+-signaling mechanisms in prokaryotes, which are 
currently not well known.  This knowledge will provide a better understanding of the 
pathogenicity of bacteria such as P. aeruginosa, and will hopefully lead to the development of 




In the earlier studies, EfhP was shown to play a role in Ca2+-induced virulence in human 
pathogen P. aeruginosa. Here we provided an experimental confirmation that EfhP selectively 
binds Ca2+. We also measured the affinity of the binding, and the elucidated Kd supports the 
hypothesis of the cytoplasmic localization of the EF hands of the protein. Furthermore, we have 
determined the role of the 1st D in the 1st EF hand in Ca2+-binding. We also showed that EfhP 
increased its hydrophobicity upon Ca2+-binding, and that decreased Ca2+-binding decreases such 
structural rearrangements. This suggests that binding Ca2+ increases the ability of the protein to 
interact with other proteins. These findings provide the foundation for further studies aiming to 




Finally, we have generated a genetic construct to identify the environmental factors 
contributing to the regulation of transcription of efhP. By identifying the host factors regulating 
efhP transcription, we will gain a better understanding of how to inhibit this protein’s function. 
The data obtained from these experiments will further characterize the role of EfhP in Ca2+ 
signaling pathways. Further analysis of this protein is needed for the development of targeted 
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